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tetrapeptides†
Huy N. Hoang, a Timothy A. Hill, a Gloria Ruiz-Go´mez,ab Frederik Diness, ac
Jody M. Mason, ad Chongyang Wu, a Giovanni Abbenante,a
Nicholas E. Shepherda and David P. Fairlie *a
Protein–protein interactions involve hotspots as small as 4 sequential amino acids. Corresponding
tetrapeptides have no structure in water. Here we report linking side chains of amino acids X and Z to
form 24 cyclic tetrapeptides, cyclo-[XAAZ]-NH2, and stabilise 14–18 membered rings that mimic
diﬀerent kinds of non-regular secondary structures found in protein hotspots. 2D NMR spectra allowed
determination of 3D structures for 14 cyclic tetrapeptides in water. Five formed two (i, i + 3) hydrogen
bonds and a beta/gamma (6, 7) or beta (9, 19, 20) turn; eight formed one (i, i + 4) hydrogen bond and
twisted into a non-helical (13, 18, 21, 22, 24) or helical (5, 17, 23) alpha turn; one was less structured (15).
A beta or gamma turn was favoured for Z ¼ Dab, Orn or Glu due to a c1 gauche (+) rotamer, while an
alpha turn was favoured for Z ¼ Dap (but not X ¼ Dap) due to a gauche () rotamer. Surprisingly, an
unstructured peptide ARLARLARL could be twisted into a helix when either a helical or non-helical alpha
turn (5, 13, 17, 18, 21–24) with Z ¼ Dap was attached to the N-terminus. These structural models provide
insights into stability for diﬀerent turns and twists corresponding to non-regular folds in protein hotspots.Introduction
Protein structure is directed by inherent preferences of amino
acids for diﬀerent folds,1 and by packing and solvation eﬀects.
Protein–protein recognition is based on interactions between
folded secondary structures like a-helices, b-strands, turns and
loops.2 Thousands of protein–protein interfaces are now known
to have bioactive ‘hotspots’ localised to just 4–8 amino acid
segments (1–2 turns),3 but 50% of those sequences have non-
regular secondary structures. They include diﬀerent subtle
variations of a-, b- and g-turns (Fig. 1), including non-helical a-
turns,4,5 underscoring the importance of gaining a better
understanding of how such turn variations dictate local struc-
ture and, ultimately, determine function. New insights toellence in Advanced Molecular Imaging,
niversity of Queensland, Brisbane, QLD
u.au
che Universita¨t Dresden, Tatzberg 47-51,
Department of Chemistry, University of
ersity of Bath, Claverton Down, Bath, BA2
(ESI) available: General experimental
sis (peptide assembly, cyclisation,
acterisation (CD, NMR), structure
tions, and extensive NMR parameters
22, Fig. S1–S40; 41 pages). See DOI:
hemistry 2019peptide folding can also enable design of small molecules
capable of mimicking diﬀerent kinds of turn motifs in proteins.
Here we investigate tetrapeptides for some new clues to how
stereochemical and structural constraints can control folding of
the peptide backbone into diﬀerent turns and helical twists.
Short peptides corresponding to bioactive sequences of
proteins rarely show stable structures in water, but when arti-
cially stabilised they can potently modulate protein–protein
interactions. A number of strategies have been described for
conformationally restricting peptides into beta-turns. One
approach is cyclisation, which can promote intramolecular
hydrogen bonds that stabilise an a-, b- or g-turn (Fig. 1).6 Each
of these turn structures is respectively sub-classied by phi and
psi angles (Tables S1 and S2, ESI†) and by Ca(i)–Ca(i + 2), Ca(i)–
Ca(i + 3), or Ca(i)–Ca(i + 4) distances between residues.Fig. 1 7-, 10-, 13-membered hydrogen bonded rings deﬁne g-, b- and
a-turns respectively (left) that potentially might be stabilised by cycli-
sation via side chains (right).
Chem. Sci., 2019, 10, 10595–10600 | 10595
Fig. 2 CD spectra of cyclic peptides (150 mM) in aqueous phosphate
buﬀer (10 mM, pH 7.4, 25 C). (A) 1–4. (B) 5–8. (C) 9–12. (D) 13–16. (E)
17–20. (F) 21–25. Standard 1-letter codes for L-amino acids unless
otherwise indicated. Dap¼ L-2,3-diaminopropionic acid; Dab¼ L-2,4-
diaminobutyric acid; O ¼ L-ornithine; Succ ¼ succinic acid; Glut ¼
glutaric acid; IsoD and Isod are L- and D-aspartic acid respectively,
where a side chain carbonyl instead forms the amide bond with the
backbone nitrogen atom of the next residue.
Chemical Science Edge Article
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View Article OnlineThe use of crosslinks between side chains of amino acids in
a peptide sequence is a robust and well-established approach to
stabilising peptide structure. Cyclisation through linking amine
and carboxylate side chains of L- or D-amino acids has been used
to enhance peptide bioactivity for many years,7 but usually
without any clear rationale or understanding of the eﬀect of the
length or positioning of the crosslink on three-dimensional
structure. The eﬀect of cyclisation on conformation is oen
inferred through improvements in activity, changes in circular
dichroism (CD) spectra, or computer simulations that predict
low energy structural ensembles. Incorporating a macrocycle
within 10–20 residue peptides oen results in local structural
changes that are diﬃcult to identify from CD spectra, which
only sample the mix of all structures present. Consequently, key
requirements for stabilising diﬀerent turn types in short
synthetic peptides are diﬃcult to ascertain from the bulk of
literature reports on short peptides. A better understanding
about how specic macrocycles can inuence structure can
enable improved design of bioactive peptides for future
mimicry of diﬀerent folded components of polypeptides.
Results and discussion
Twenty-four cyclic tetrapeptides (cyclo-1,4)-[XAAZ]-NH2 (1–24)
were synthesised, varying in ring size from 14–18 atoms (Table
S3, ESI†). In each case X and Z have a side chain to side chain
linkage between basic (L-Lys, L-Orn, L-Dab, L-Dap) and either
an acidic (L-Asp, D-Asp, L-isoAsp, D-isoAsp, L-Glu, D-Glu) amino
acid or a diacid (succinic, glutaric), with two intervening Ala
residues. They were then systematically examined to discover
how side chain-to-side chain cyclisation of residues at the ends
of tetrapeptides can aﬀect folding into diﬀerent turn motifs in
water, using circular dichroism (CD) spectra in conjunction
with 2D 1H-NMR spectroscopy and molecular dynamics (MD)
simulations to characterise peptide structure.
Structural diﬀerences were rst monitored by CD spectra in
water (Fig. 2). Peptides 1–3, 5, 6, 9 and 13 produced two negative
molar ellipticity minima between l  200–220 nm, these
wavelengths being expected for helical peptides.8 Peptides 1–3,
6 and 9 also had a positive maximum at 185 nm. Larger
macrocycles (>16 atoms) 4, 8, 11, 12, 15, 16 gave less prominent
CD line shapes, while 17–20 containing X ¼ D-amino acid gave
unusual CD spectra. For X ¼ a carboxylic acid, where the rst
amide group (Ac-X) has been moved (21 and 22) or removed (23
and 24), molar ellipticities were more intense and spectral
patterns were more similar to that for the structurally well-
characterised a-helix of cyclic pentapeptide Ac-(cyclo-1,5)-
[KAAAD]-NH2 (25),6d,e perhaps suggesting some type of helix.5
While 21–25 appear to be helical structures, the other
compounds are of less certain structural identity but they do
serve as useful ngerprints diagnostic of the structure or mix of
structures present in water. Overall, there was however a trend
where a-turn structures (i.e. 5, 17, 18, 21, 22, 23 and 24) gave
a more intense molar ellipticity at l  215 nm than b-turn
structures (i.e. 6, 7, 9, 15, 19 and 20) (Fig. S1, ESI†).
CD spectra are based on absorption of le versus right
circularly polarized light by amide bonds formed between chiral10596 | Chem. Sci., 2019, 10, 10595–10600amino acids, but tetrapeptides consist only of a few amides.
While CD spectral traces are commonly used to interpret three-
dimensional structure in peptides, they more oen lead to
incorrect interpretations of peptide structure,9whereas 2D NMR
spectra usually give rise to much more reliable structural
characterisations.
To investigate three dimensional structure, we next analysed
1H NMR spectra for 1–24 in 9 : 1 H2O : D2O, cataloguing their
amide coupling constants (3JNH–CHa) that inform on residue phi
angles (Table S5, ESI†), and their amide proton temperature
coeﬃcients (Dd/DT) suggestive of hydrogen bonds (Table S6,
ESI†). Fieen peptides had 1–3 b-strand-like (>8 Hz) or a-helix-
like (<6 Hz) coupling constants (3JNH–CHa). Peptides 5–7, 9, 13
and 15 had a C-terminal amide proton with Dd/DT < 4 ppb K1,
while 6, 7, 9 and 15 had an i + 3 amide proton with Dd/DT <
4 ppb K1, suggesting possible hydrogen bonds. 2D ROESY
spectra for peptides 5–7, 9, 13, 15 in water showed 34–46
intramolecular ROEs, that is consistent with well-dened
structure (Tables S9–S22, ESI†). NMR structure calculations
indicated that these peptides were turn-like over the three
residues AAZ, with peptides 5, 7, 13 giving prominent a-N(i, i +
2), a-N(i, i + 3), b-N(i, i + 4) ROEs. However, each N-terminalThis journal is © The Royal Society of Chemistry 2019
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
O
ct
ob
er
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
2/
16
/2
01
9 
9:
57
:1
7 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineacetyl moiety projected outwards and was unable to form an
intramolecular hydrogen bond for X to be in a helix.
Inverting the chirality from L-Asp1 (5–7) or L-Glu1 (13) to D-
Asp1 (17, 19–20) or D-Glu1 (18) caused the Ac-NH to reposition
closer to the peptide backbone, so that the CH3CO– group
might form another hydrogen bond. Peptides 17–20 with a D-
residue all had 3JNH–CHa amide coupling constants < 6 Hz for
Ala2 and Ala3, and a C-terminal amide proton with Dd/DT <
4 ppb K1. Peptides 19 and 20 also had Dd/DT < 4 ppb K1 for
the amide proton of residue 4. 2D ROESY spectra of 17–20
showed 43–71 ROEs and calculated NMR structures (Fig. 3)
revealed almost identical structures to their corresponding L-
residue analogues (5–7 and 13) (Fig. 3). The Ac-NHmoiety in 17–
20 was now positioned closer to the helix/turn core, but the
acetyl carbonyl oxygen atom was pointing outward. NMR
structures suggested no i/ i + 3 or i/ i + 4 hydrogen bonds.
To relocate or remove the Ac-NH moiety, we further synthesisedFig. 3 NMR summaries, 20 lowest energy structures, Ramachandran plo
15, 17–24 in H2O/D2O (9 : 1) at 298 K. Compounds 5, 13, 17, 18, 21–24
bonds.
This journal is © The Royal Society of Chemistry 201921–24. Peptides 21–23 had only one 3JNH–CHa amide coupling
constant < 6 Hz (for Ala2), while 24 had amide coupling
constants < 6 Hz for both Ala2 and Ala3. All these peptides (21–
24) had two Dd/DT < 4 ppb K1 for the amide protons of residue
4 and C-terminal amide. Thus, NMR data indicated an a-turn
structure4,5 for 21–24 in water.
To further characterise structure ensembles for 5–7, 9, 13, 15
and 17–24, average phi and psi angles were compared with
those found in classical or idealised a- and 310-helices, b- and
specialised a-turns4 (where phi, psi ¼ 58, 47 or 60,30
dene idealised classical a- or 310-helical turns, respectively)
(Tables S1, S2 and S8, ESI†). NMR-derived structures were
superimposed upon these idealised turns and the average
backbone RMSDs were calculated to support their structural
classications. In all cases, the rst residue X1 did not correlate
with any structure. This ts well with our ability to stereo-invert
or relocate or remove the rst residue, whilst maintainingts and turn types in water for fourteen cyclic tetrapeptides: 5–7, 9, 13,
form one hydrogen bond; while 6, 7, 9, 15, 19, 20 form two hydrogen
Chem. Sci., 2019, 10, 10595–10600 | 10597
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View Article Onlinesimilar overall structures in residues Ala2–Ala3–Z4. Phi and psi
angles across these three residues correlated best with an 0a-RS
turn for 5, 17 and 23, but with a b(III) turn across residues Ala2–
Ala3 for 6, 7, 9, 19, 20. These angles were variable in residue Z4,
in some cases indicating an inverse g-turn (6, 7) or b(I)-turn (19,
20). Peptides 13, 18, 21, 22, 24 correlated with an Ia-RS turn
across Ala2–Ala3. Peptide 15 only showed a-helix or b(III)-turn
character in residue Ala2, all other residues were variable.
Since the cyclisation constraint aﬀects structure stabilisa-
tion, we also examined the c1 angle for residue Z4 (Fig. 4). The
gauche () rotamer was adopted for Dap4-containing 5 (+58)
and 17 (+59). This c1 angle optimally positions the constraint
for i/ i + 4 hydrogen bond formation. Peptides 13 (c1 ¼ +50)
and 18 (c1¼ +41) were next closest. For the remaining peptides
with a larger side chain in residue Z4, the c1 angle gradually
shied towards the gauche (+) rotamer: e.g.Dab-containing 6 (c1
¼28) and 19 (c1 ¼23). For b(III)-like Orn-containing 7 (c1
¼ 58) and 20 (c1 ¼ 59), this rotamer enabled two i/ i + 3
hydrogen bonds to form. MD simulations for 5–7, 9, 13, 15 and
17–20 supported this nding (Fig. 4A).
To summarise Fig. 4, cyclic tetrapeptides with a small side
chain at the fourth residue (Z¼ Dap) favoured c1 in a gauche ()
conguration, which stabilised a psi dihedral angle of40  10
and a C-terminal amide NHwas involved in an i/ i + 4 hydrogen
bond. By contrast, a larger side chain for Z ¼ Dab, Orn, Glu
favoured a lower energy conformation, c1 for gauche (+). NMR
structures of peptides where Z ¼ Dap (5, 13, 17, 18, 21–24) had
residues Ala2–Ala3–Dap4 and the C-terminal amide folded into a-
turn structures. Amide carbonyls were aligned to potentially
accept hydrogen bonds from amide protons in a peptide
appended to the C-terminus of Dap. A distinctive diﬀerence
between these structures was the intramolecular hydrogen
bonding network. One i / i + 4 hydrogen bond was found in
peptides 5, 13, 17, 18 and 21–24, whereas two i/ i + 3 hydrogenFig. 4 (A) Rotamer populations for residue Z4 from 50 ns MD simu-
lations of cyclic peptides 5–20. NMR structures of: (B) 7 and 5 show
how the c1 angle of residue Z4 controls b(III)-turn vs. a-turn structures.
10598 | Chem. Sci., 2019, 10, 10595–10600bonds were present in 6, 7, 9, 15, 19 and 20 (Fig. 3). We therefore
considered that 5, 13, 17, 18 and 21–24 could be potential N-
terminal helix nucleators as their structures support an i/ i +
4 hydrogen bond that is crucial in an a-helical structure.
Next, we searched the PDB for examples of a-helix, a-turn, b-III
and b-I turns in hotspots of proteins. We superimposed (PyMOL)
our cyclic peptide structures from Fig. 3, calculated by NMR and
validated by MD simulations (Fig. 4A), upon three consecutive
residues of the protein secondary structures (Fig. 5). Examples
spanned classical a-helix (0a-RS), a-turn (Ia-RS), b-turn type III (310-
helix), b-turn type I and g-turn in 12 diﬀerent protein crystal
structures. These diﬀerent protein turns play important structural
roles within human, mammalian and bacterial proteins of very
diverse functions. The successful structural mimicry here of these
important protein structural motifs by small cyclic peptidesFig. 5 Average backbone solution structures of 5–7, 9, 15, 17–21 and
23–24 (green; residues: A, A, X/Z) superimposed on the three central,
consecutive, residues of an a-helix, a-turn, b-III turn and b-I turn from
protein crystal structures (yellow). The linkers in these compounds are
coloured grey.
This journal is © The Royal Society of Chemistry 2019
Table 1 Relative helix nucleation in 27–40 by cycles 5–25a
# Sequence Cycle fH (buﬀer) [q222]/[q208]
27 Ac-cyclo-[DAADap]-(ARL)3-NH2 5 0.42 1.15
28 Ac-cyclo-[DAADab]-(ARL)3-NH2 6 0.31 0.84
29 Ac-cyclo-[DAAO]-(ARL)3-NH2 7 0.29 0.74
30 Ac-cyclo-[DapAAE]-(ARL)3-NH2 9 0.29 0.73
31 Ac-cyclo-[EAADap]-(ARL)3-NH2 13 0.42 0.85
32 Ac-cyclo-[EAAO]-(ARL)3-NH2 15 0.36 0.75
33 Ac-cyclo-[dAADap]-(ARL)3-NH2 17 0.54 0.98
34 Ac-cyclo-[eAADap]-(ARL)3-NH2 18 0.45 0.96
35 Ac-cyclo-[dAAO]-(ARL)3-NH2 20 0.36 0.77
36 Ac-cyclo-[isoDAADap]-(ARL)3-NH2 21 0.66 1.08
37 Ac-cyclo-[isodAADap]-(ARL)3-NH2 22 0.61 0.98
38 Cyclo-[SuccAADap]-(ARL)3-NH2 23 0.65 1.03
39 Cyclo-[GlutAADap]-(ARL)3-NH2 24 0.52 0.91
40 Ac-cyclo-[KAAAD]-(ARL)3-NH2 25 0.59 1.02
a 10 mM phosphate buﬀer (pH 7.4, 25 C), [peptide] ¼ 125 mM.
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View Article Onlineprovides new capacity to study these structures independent of
packing inuences in proteins.
Finally, we appended these cyclic tetrapeptides to the N-
terminus of nonapeptide ARLARLARL-NH2 (26) to give 27–39.
For comparison, we also appended cyclic pentapeptide Ac-
[KAAAD]- (25) to 26 to give 40. The relative percent a-helicity
was measured from CD spectra using fractional helicities (fH)
calculated in 10 mM phosphate buﬀer (Table 1). Each cyclic tet-
rapeptide had a diﬀerent a-helix nucleating capacity (fH 0.29–
0.66) when attached to the N-terminus of the non-helical peptide
26 (fH ¼ 0.12). The N-capped 9-residue peptides with the best
helix induction (Table 1) were 36–38, 40 (fH $ 0.59) > 33, 39 (fH
0.53) > 27, 31, 34 (fH 0.43) where an a-turn was appended.
These data show how subtle diﬀerences in cyclic tetrapeptide
structure permit or prevent helix nucleation. None of the cyclic
tetrapeptides alone has its key carbonyl groups perfectly aligned
for helix induction within the cycle itself, yet some are suﬃciently
aligned to nucleate helicity in attached peptides.Conclusions
We synthesised and characterised 24 cyclic tetrapeptides, Ac-
(cyclo-1,4)-[XAAZ]-NH2, using diﬀerent i/ i + 3 side chain amide
crosslinks for cyclization. Such crosslinks have been widely used
to improve the bioactivity of peptides, however the cyclic tetra-
peptide structures were unknown or inferred on the basis of CD
spectral line-shapes, which usually lead to incorrect structure
assignments. Here we combined 2D ROESY spectra, amide
coupling constants, temperature coeﬃcients and MD simulations
to determine their three-dimensional structures in water. Four-
teen crosslinked macrocycles were studied with a ring size of 14–
16 atoms (5–7, 9, 13, 15, 17–24) that gave stable structures in water
(Fig. 3). The smaller 14-membered rings tended to be a-turns; 5,
17 and 23were 0a-RS turns,5while 21 and 22were Ia-RS turns4 and 1
was unstructured. The 15-membered rings adopted b-turns (6, 9,
19) or Ia-RS turns4 (13, 18, 24), with 2 being unstructured. The 16-
membered rings were either b-III turns (7, 20) or did not show
stable structures (3, 10, 14). Larger macrocycles with 17- (4, 8, 11,This journal is © The Royal Society of Chemistry 201915) or 18- (12, 16) membered rings gave unstable or less stable
structures in water (Table S3, ESI†). All a-turn structures (5, 13, 17,
18, 21–24) had a residue with a small side chain Dap at position Z,
with its c1 angle dening a gauche () conguration and favoured
one i/ i + 4 hydrogen bond. On the other hand, b-turn structures
were observed for peptides (6, 7, 9, 19, 20) with residues having
larger side chains (Dab, Orn, Glu) at this position and favoured
two i / i + 3 hydrogen bonds. These results contrast with
a previous report that suggested some of these bridges form b-II
and g-turns, but those peptides also contained turn-promoting
residues (proline, glycine).7c The Ac-NH moiety in 5–7, 9, 13, 15
did not stabilise the structures. Inverting chirality from L- to D- (17–
20), or repositioning (21, 22) or removing (23, 24) the N-terminal
Ac-NH moiety, preserved turn structure in the last three residues
2–4 (AAZ).
Each of these model cyclic tetrapeptides were found to
successfully mimic corresponding a-helix, a-turn, b-III turn and
b-I turn secondary structural components found in biologically
important locations in proteins, suggesting the potential for
future mimicry of functional properties of such important
irregular structures at hotspots in proteins.
We also investigated helix nucleation by these cyclic tetra-
peptides at the N-terminus of a non-helical 9-residue peptide
sequence ARLARLARL-NH2 (Table 1). Tetrapeptides forming
b(III)-turns (e.g. 6, 7, 9, 20), favouring a gauche (+) conformation
and two i/ i + 3 hydrogen bonds, induced less helicity than a-
turn forming 5 and 13, which showed a gauche () conforma-
tion and one i/ i + 4 hydrogen bond. Cyclic tetrapeptides with
D- rather than L-residues at the (i) position X were better helix
nucleators (17 vs. 5, 18 vs. 13). Cyclic tetrapeptides Ac-[(isoD or
d)AADap]-NH2 (21 or 22)10 and cyclic pentapeptide 25 6e have
been reported previously. We nd that they were better nucle-
ators than 17 and 18. Achiral diacid(i)/ Dap(i + 3) crosslinks
were also eﬃcient helix nucleators. Succinate at the i position
(23) was as good, or better, a helix nucleator than isoaspartate
22 or 25. Interestingly, the glutarate linker (24) was also an
eﬀective nucleator (equal to 17), and such dicarboxylate(i) /
Dap(i + 3) linked tetrapeptides are important new N-terminal
helix-nucleating templates easily synthesised, requiring fewer
protecting group strategies and cheaper to make than most
macrocycles herein.
These new insights into stereochemical and structural
inuences on peptide folding have led to better denition of
peptide turns and helical twists, which mimic the nonregular
secondary structures found in bioactive hotspots of proteins,
and can inspire design of small molecules to structurally and
functionally mimic some of the many subtly diﬀerent turns and
helices in proteins.
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